Resultater fra en epidemiologisk undersøgelse viste, at der ikke var en øget risiko for selvmord med aripiprazol sammenlignet med andre antispsykotika, hos patienter med bipolar lidelse.
Results of an epidemiological study found that there was no increased risk of suicidality with aripiprazole compared to other antipsychotics among patients with bipolar disorder.